𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic choices for patients with hemophilia and high-titer inhibitors

✍ Scribed by Roshni Kulkarni; Louis M. Aledort; Erik Berntorp; Hans H. Brackman; Deborah Brown; Alan R. Cohen; Nadia P. Ewing; Alessandro Gringeri; Ralph Gruppo; Keith Hoots; Cindy Leissenger; Katheliijne Peerlinck; Man-Chiu Poon; Wing-Yen Wong

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
28 KB
Volume
69
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutic choices for patients with he
Therapeutic choices for patients with hemophilia and high-titer inhibitors
✍ Roshni Kulkarni; Louis M. Aledort; Erik Berntorp; Hans H. Brackman; Deborah Brow πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 41 KB

Effective treatment of bleeding episodes in hemophilia with high titer inhibitors (HTI) remains a challenge, despite the fact that the therapeutic armamentarium has expanded considerably over the past few years. Treatment safety has improved with the availability of porcine factor VIII (FVIII) and b

Factors affecting choice of hemostatic a
Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody
✍ Paul E. Monahan; Louis M. Aledort πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 3 views

## Abstract Achieving adequate hemostasis in patients with hemophilia and high‐titer inhibitor antibodies remains a challenge despite the development of plasma‐derived and recombinant therapies to bypass the inhibitory effect. A group of hemophilia treaters met to examine the factors that influence